http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102488825-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91b90d4b55cb0a5d52699465e22484c0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
| filingDate | 2011-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60eedbf1f1cdfa7a8b9a451e7bed1673 |
| publicationDate | 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102488825-B |
| titleOfInvention | Traditional Chinese medicine composition for treating beriberoid pyretic arthralgia and application of traditional Chinese medicine composition |
| abstract | The invention provides a traditional Chinese medicine composition for treating beriberoid pyretic arthralgia and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition consists of berba aristolochiae mollissimae, caulis sinomenii, radix cudramiae, rhizoma atractylodis and rhizoma anemarrhenae, wherein, the medicine is prepared from the following raw material in parts by weight: 1-1.5 of berba aristolochiae mollissimae, 2-2.5 of caulis sinomenii, 2-2.5 of radix cudramiae, 1-1.5 of rhizoma atractylodis and 1-1.5 of rhizoma anemarrhena. The berba aristolochiae mollissimae is monarch drug, the caulis sinomenii and the radix cudramiae are minister drugs, and the rhizoma atractylodis and the rhizoma anemarrhenae are assistant drugs. The traditional Chinese medicine composition is rigorousin compatibility of medicines, excellent in pharmacy and reliable in clinical effect, and after the traditional Chinese medicine composition is clinically applied to 198 patients with beriberoid pyretic arthralgia, total effective rate achieves 91.3%. The patients are examined in detail in therapy processes, the patients in different groups do not have obvious adverse reaction, safety indexes including blood routine, liver functions, renal functions, urine routine and the like of the patients are detected before and after the patients are treated by the heat clearing and beriberoid pyretic arthralgia removing prescription, various indexes do not have statistics differences after being compared, in other words, the heat clearing and beriberoid pyretic arthralgia removing prescription is good in safety, and the traditional Chinese medicine composition is a safe and effective medicine for treating rheumatism, and has wide development and application prospect. |
| priorityDate | 2011-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.